+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5893230
Description Jump to:

Critical Care Diagnostics Market Growth & Trends

The global critical care diagnostics market size is expected to reach USD 2.10 billion by 2030. The market is expected to grow at a CAGR of 6.11% from 2025 to 2030. The key factors supporting the industry’s growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 7.24% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU’s. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights

  • The Asia Pacific region is expected to grow at the fastest CAGR of 8.0% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU’s, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.5. Market Restraint Analysis
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
Chapter 4. Type Business Analysis
4.1. Critical Care Diagnostics Market: Type Movement Analysis
4.2. Routine & Special Chemistry
4.2.1. Routine & Special Chemistry Market, 2018 - 2030 (USD Million)
4.3. Flow Cytometry
4.3.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
4.4. Hematology
4.4.1. Hematology Market, 2018 - 2030 (USD Million)
4.5. Immunoproteins
4.5.1. Immunoproteins Market, 2018 - 2030 (USD Million)
4.6. Microbial & Infectious Disease
4.6.1. Microbial & Infectious Disease Market, 2018 - 2030 (USD Million)
4.7. Coagulation Testing
4.7.1. Coagulation Testing Market, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-use Business Analysis
5.1. Critical Care Diagnostics Market: End-use Movement Analysis
5.2. Operation Room
5.2.1. Operation Room Market, 2018 - 2030 (USD Million)
5.3. Intensive Care Unit
5.3.1. Intensive Care Unit Market, 2018 - 2030 (USD Million)
5.4. Emergency Rooms
5.4.1. Emergency Rooms Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Critical Care Diagnostics Market Share By Region, 2024 & 2030
6.2. North America
6.2.1. North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Target Disease Prevalence
6.2.2.3. Competitive Scenario
6.2.2.4. Regulatory Framework
6.2.2.5. Reimbursement Scenario
6.2.2.6. U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD MILLION)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. Reimbursement Scenario
6.2.3.6. Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Reimbursement Scenario
6.2.4.6. Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Critical diagnostics Market, 2018 - 2030 (USD Million)
6.3.2. Germany
6.3.2.1. Key Country Dynamics
6.3.2.2. Target Disease Prevalence
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.2.5. Reimbursement Scenario
6.3.2.6. Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Reimbursement Scenario
6.3.3.6. UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Reimbursement Scenario
6.3.4.6. France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. Reimbursement Scenario
6.3.5.6. Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Reimbursement Scenario
6.3.6.6. Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Reimbursement Scenario
6.3.7.6. Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Reimbursement Scenario
6.3.8.6. Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Reimbursement Scenario
6.3.9.6. Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.2.5. Reimbursement Scenario
6.4.2.6. Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Reimbursement Scenario
6.4.3.6. China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. Reimbursement Scenario
6.4.4.6. India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. Reimbursement Scenario
6.4.5.6. South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Reimbursement Scenario
6.4.6.6. Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Reimbursement Scenario
6.4.7.6. Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.2.5. Reimbursement Scenario
6.5.2.6. Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Reimbursement Scenario
6.5.3.6. Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Critical diagnostics Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.2.5. Reimbursement Scenario
6.6.2.6. South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. Reimbursement Scenario
6.6.3.6. Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Reimbursement Scenario
6.6.4.6. UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. Reimbursement Scenario
6.6.5.6. Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. Abbott
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Collection Site Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Danaher
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Collection Site Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Siemens Healthineers
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Collection Site Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. F. Hoffmann-La Roche Ltd.
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Collection Site Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Quidel Corporation
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Collection Site Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. bioMérieux S.A
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Collection Site Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Chembio Diagnostics, Inc.
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Collection Site Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. EKF Diagnostics
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Collection Site Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Bayer AG
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Collection Site Benchmarking
7.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 Global Critical Care Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 8 North America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 10 U.S. Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 11 Mexico Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 12 Mexico Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 13 Canada Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 14 Canada Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 15 Europe Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 16 Europe Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 17 Europe Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 18 Germany Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 19 Germany Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 20 UK Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 21 UK Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 22 France Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 23 France Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 24 Italy Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 25 Italy Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 26 Spain Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 27 Spain Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 28 Denmark Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 29 Denmark Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 30 Sweden Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 31 Sweden Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 32 Norway Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 33 Norway Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 37 China Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 38 China Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Japan Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 40 Japan Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 41 India Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 42 India Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 43 South Korea Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 44 South Korea Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 45 Australia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 46 Australia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 47 Thailand Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 48 Thailand Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 49 Latin America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 50 Latin America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 51 Latin America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 52 Brazil Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 53 Brazil Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 54 Argentina Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 55 Argentina Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 59 South Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 60 South Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 63 UAE Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 64 UAE Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 65 Kuwait Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
Table 66 Kuwait Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Critical Care Diagnostics Market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global Critical Care Diagnostics Market: Type Movement Analysis
Fig. 16 Global Critical Care Diagnostics Market, for Routine & Special Chemistry, 2018 - 2030 (USD Million)
Fig. 17 Global Critical Care Diagnostics Market, for Flow Cytometry, 2018 - 2030 (USD Million)
Fig. 18 Global Critical Care Diagnostics Market, for Hematology, 2018 - 2030 (USD Million)
Fig. 19 Global Critical Care Diagnostics Market, for Immunoproteins, 2018 - 2030 (USD Million)
Fig. 20 Global Critical Care Diagnostics Market, for Microbial & Infectious Disease, 2018 - 2030 (USD Million)
Fig. 21 Global Critical Care Diagnostics Market, for Coagulation Testing, 2018 - 2030 (USD Million)
Fig. 22 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
Fig. 23 Global Critical Care Diagnostics Market: End-use Movement Analysis
Fig. 24 Global Critical Care Diagnostics Market, for Operation Room, 2018 - 2030 (USD Million)
Fig. 25 Global Critical Care Diagnostics Market, for Intensive Care Unit, 2018 - 2030 (USD Million)
Fig. 26 Global Critical Care Diagnostics Market, for Emergency Rooms, 2018 - 2030 (USD Million)
Fig. 27 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional Outlook, 2024 & 2030
Fig. 30 Global Critical Care Diagnostics Market, Region Movement Analysis
Fig. 31 North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 32 U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 33 Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 34 Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 35 Europe Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 36 Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 37 UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 38 France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 39 Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 40 Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 41 Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 42 Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 43 Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 45 Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 46 China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 47 India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 48 Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 49 South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 50 Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 51 Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 52 Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 53 Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 55 South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 57 UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • BD
  • EKF Diagnostics
  • bioMérieux, Inc.
  • Siemens Healthcare Private Limited
  • Chembio Diagnostics, Inc.
  • Bayer AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.45 billion
Forecasted Market Value ( USD ) by 2030 $ 2.1 billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Critical Care Diagnostics Market by Test, End-User - Global Forecast 2025-2030 - Product Image

Critical Care Diagnostics Market by Test, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Critical Care Equipment Market by Product Type, End-User - Global Forecast 2025-2030 - Product Image

Critical Care Equipment Market by Product Type, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Critical Care Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Critical Care Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 114 Pages
  • Global
From
Critical Care Diagnostics - Global Strategic Business Report - Product Image

Critical Care Diagnostics - Global Strategic Business Report

  • Report
  • 256 Pages
  • Global
From
Critical Care Antiarrhythmic Drugs Global Market Report 2024 - Product Image

Critical Care Antiarrhythmic Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.